Evidence against peroxisome proliferation-induced hepatic oxidative damage: Levels of esterified isoprostanes in livers of mice fed a diet containing [4-chloro-6- (2,3-xylidino)-2-pyrimidinylthioiacetic acid (WY- 14,643)

Biochemical Pharmacology

Volumn 53, Issue 9, 1997, Pages 1369-1374

  Soliman, Mahmoud S ^a   Cunningham, Michael L ^b   Morrow, Jason D ^c   Roberts II, L Jackson ^c   Badr, Mostafa Z ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

Hepatocarcinogenesis; Isoprostanes; Lipid peroxidation; Oxidative damage; Peroxisome proliferation

Indexed keywords

PEROXISOME PROLIFERATOR; PIRINIXIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; HEPATOMEGALY; LIVER INJURY; MALE; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL;

EID: 0030835443     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)87956-7     Document Type: Article

References (42)

1. Kawashima Y, Katoh H and Kozuka H, Differential effects of altered hormonal state on the induction of acyl-CoA hydrolases and peroxisomal β-oxidation by clofibric acid. Biochim Biophys Acta 750: 365-372, 1983.
2. Reddy JK and Lalwai ND, Carcinogenesis by hepatic peroxisome proliferators: Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. Crit Rev Toxicol 12: 1-58, 1983.
3. Chen H, Huang C-y, Wilson MW, Lay LT, Robertson LW, Chow CK and Glauert HP, Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats. Carcinogenesis 15: 2847-2850, 1994.
4. James NH and Roberts RA, The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes. Carcinogenesis 15: 2687-2694, 1994.
5. Butterworth BE, Bermudez E, Smith-Oliver T, Earle L, Cattley R, Martin J, Popp JA, Strom S, Jirtle R and Michalopoulos G, Lack of genotoxic activity of di(2-ethylhexyl)phthalate (DEHP) in rat and human hepatocytes. Carcinogenesis 5: 1329-1335, 1984.
6. Rao MS, Ide H, Yeldandi AV, Kumar S and Reddy JK, Expression of peroxisomal enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase enzyme and its mRNA in peroxisome proliferator-induced liver tumors. Carcinogenesis 15: 2619-2622, 1994.
7. Lazarow PB, Three hypolipidemic drugs increase hepatic palmitoyl-CoA oxidation in the rat. Science 197: 580-581, 1977.
8. Badr MZ, Induction of peroxisomal enzyme activities by di(2-ethylhexyl)phthalate in thyroidectomized rats with parathyroid replants. J Pharmacol Exp Ther 263: 1105-1110, 1992.
9. Thottassery J, Winberg L, Youssef J, Cunningham M and Badr M, Regulation of perfluorooctanoic acid-induced peroxisomal enzyme activities and hepatocellular growth by adrenal hormones. Hepatology 15: 316-322, 1992.
10. Furukawa K, Numoto S, Furuya K, Furukawa NT and Williams GM, Effect of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital. Cancer Res 45: 5011-5019, 1985.
11. Reddy JK, Azarnoff DL and Hignite CE, Hypolipidaemic hepatic peroxisome proliferators form a novel class of chemical carcinogens. Nature 283: 397-398, 1980.
12. Reddy JK, Carcinogenicity of peroxisome proliferators: Evaluation and mechanisms. Biochem Soc Trans 18: 92-94, 1990.
13. 2 production in intact liver. Toxicol Lett 60: 61-68, 1992.
14. Marsman DS, Goldworthy TL and Popp JA, Contrasting hepatocytic peroxisome proliferation, lipofuscin accumulation and cell turnover for the hepatocarcinogens Wy-14,643 and clofibric acid. Carcinogenesis 13: 1011-1017, 1992.
15. Conway JG and Popp JA, Effect of the hepatocarcinogenic peroxisome proliferator Wy-14,643 in vivo: No increase in ethane exhalation or hepatic conjugated dienes. Toxicol Appl Pharmacol 135: 229-236, 1995.
16. Marsman DS, Cattley RC, Conway JG and Popp JA, Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid (WY-14,643) in rats. Cancer Res 48: 6739-6744, 1988.
17. Cattley RC, Marsman DS and Popp JA, Age-related susceptibility to the carcinogenic effect of the peroxisome proliferator WY-14,643 in rat liver. Carcinogenesis 12: 469-473, 1991.
18. Eacho PI, Lanier TL and Brodhecker CA, Hepatocellular DNA synthesis in rats given peroxisome proliferating agents: Comparison of WY-14,643 to clofibric acid, nafenopin and LY171883. Carcinogenesis 12: 1557-1561, 1991.
19. Kraupp-Grasl B, Huber W, Taper H and Schuke-Hermann R, Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously. Cancer Res 51: 666-671, 1991.
20. 2-isoprostane) metabolites in human urine and plasma. J Biol Chem 268: 4161-4169, 1993.
21. Morrow JD, Minton TA, Mukundan CR, Campbell MD, Zackert WE, Daniel VC, Badr KF, Blair IA and Roberts LJ II, Free-radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes. J Biol Chem 269: 4317-4326, 1994.
22. 2-Isoprostanes produced by non-cyclooxygenase free radical-catalyzed mechanism. Methods Enzymol 233: 163-174, 1994.
23. Morrow JD and Roberts LJ II, The isoprostanes. Current knowledge and directions for future research. Biochem Pharmacol 51: 1-9, 1996.
24. 2-isoprostanes) in carbon tetrachloride hepatotoxicity: An animal model of lipid peroxidation. J Clin Invest 90: 2502-2507, 1992.
25. 2-isoprostanes. J Nutr 124: 810-816, 1994.
26. 2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 332: 1198-1203, 1995.
27. Lazarow PB and DeDuve C, A fatty acyl-CoA oxidizing system in rat liver peroxisomes: Enhancement by clofibrate, a hepolipidemic drug. Proc Nad Acad Sci USA 73: 2043-2046, 1976.
28. Aebi H, Catalase. In: Methods of Enzymatic Analysis (Ed. Bergmeyer H), pp. 673-684. Academic Press, New York, 1974.
29. Rao MS, Lalwani ND, Watanabe TK and Reddy JK, Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator. Cancer Res 44: 1072-1076, 1984.
30. Kasai H, Okada Y, Nishimura S, Rao MS and Reddy JK, Formation of 8-hydroxydeoxyguanosine in liver DNA of rats following long-term exposure to a peroxisome proliferator. Cancer Res 49: 2603-2605, 1989.
31. Takagi A, Sai K, Umemura T, Hasegawa R and Kurokawa Y, Significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats following short-term exposure to the peroxisome proliferators di(2-ethylhexyl)phthalate and di(2-ethylhexyl)adipate. Jpn J Cancer Res 81: 213-215, 1990.
32. Takagi A, Sai K, Umemura T, Hasegawa R and Kurokawa Y, Short-term exposure to the peroxisome proliferators, perfluorooctanoic acid and perfluorodecanoic acid, causes significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats. Cancer Lett 57: 55-60, 1991.
33. Szweda LI, Age-related increase in liver retinyl palmitate: Relationship to lipofuscin. J Biol Chem 269: 8712-8715, 1994.
34. Hegi ME, Ulrich D, Sagelsdorff P, Richter C and Lutz WK, No measurable increase in thymidine glycol or 8-hydroxydeoxyguanosine in liver DNA of rats treated with nafenopin or choline-devoid low-methionine diet. Mutat Res 238: 325-329, 1990.
35. Cattley RC and Glover SE, Elevated 8-hydroxydeoxyguanosine in hepatic DNA of rats following exposure to peroxisome proliferators: Relationship to carcinogenesis and nuclear localization. Carcinogenesis 14: 2495-2499, 1993.
36. Huang C-y, Wilson MW, Lay LT, Chow CK, Robertson LW and Glauert HP, Increased 8-hydroxydeoxyguanosine in hepatic DNA of rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid. Cancer Lett 87: 223-228, 1994.
37. 2-isoprostane production and cytolysis in renal tubular epithelial cells. J Am Soc Nephrol 6: 1300-1303, 1995.
38. Burk RF, Hill KE, Awad JA, Morrow JD, Kato T, Cockell KA and Lyons PR, Pathogenesis of diquat-induced liver necrosis in selenium-deficient rats: Assessment of the roles of lipid peroxidation and selenoprotein P. Hepatology 21: 561-569, 1995.
39. 2-isoprostanes and malondialdehyde in peroxidizing rat liver microsomes. Biochem Pharmocol 47: 1173-1177, 1994.
40. Morrow JD and Roberts LJ II, Quantification of noncyclooxygenase derived prostanoids as a marker of oxidation stress. Free Radic Biol Med 10: 195-200, 1991.
41. Olson CT and Andersen ME, The acute toxicity of perfluorooctanoic and perfluorodecanoic acids in male rats and effects on tissue fatty acids. Toxicol Appl Pharmacol 70: 362-372, 1983.
42. Kawashima Y, Nishizawa H and Kozuka H, Reduction by clofibric acid of serum arachidonic acid in rats. Effect on the acyl composition of renal phospholipids. Biochem Pharmacol 43: 2321-2326, 1992.